Gastroenterology

Papers
(The H4-Index of Gastroenterology is 93. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
An Unusual Case of Gallbladder Emergency684
SOX9 Expression Pattern and Its Prognosis in Gastric Cancer Should be Fully Evaluated584
In Memoriam: David A. Ahlquist, MD559
713f Histologic Activity in Ulcerative Colitis Patients Achieving Endoscopic Healing is Associated with Higher Rate of Relapse and a Distinct Mucosal Microbial and Transcriptional Profile535
Editorial Board499
Elsewhere in The AGA Journals (Preview Section)442
Spotlight415
Mo1129 PHASE 3 BIOMARKER STUDY FOR HCC SURVEILLANCE USING A NOVEL HES V2.0 ALGORITHM. A PROSPECTIVE COLLECTION WITH RETROSPECTIVE BLINDED EVALUATION400
Information for Authors and Readers389
Elsewhere in The AGA Journals345
Table of Contents333
Clinical Decision Support Tool: IBS Treatment333
Cover 1313
Editorial Board243
Sa1247 NEW INSIGHTS ON THE MECHANISM OF ACTION OF HYOSCINE BUTYLBROMIDE (HBB) IN THE HUMAN COLON: HBB MODULATES EFFECT OF NEURONAL AND NON-NEURONAL ACETYLCHOLINE228
Sa1244 BIOPHYSICAL PROPERTIES OF GASTROINTESTINAL SMOOTH MUSCLE CELL MECHANOGATED CHANNEL TMEM63A217
224 EXTERNAL VALIDATION OF A DEEP LEARNING MODEL FOR WHOLE SLIDE IMAGE ANALYSIS IN THE HISTOLOGIC DIAGNOSIS OF DYSPLASTIC BARRETT'S ESOPHAGUS215
288 OPTICAL COHERENCE TOMOGRAPHY GUIDED LASER CAPTURING OF GASTROINTESTINAL TRACT TISSUE FOR GENOMIC ANALYSIS208
699 SAFETY OUTCOMES AND CONCOMITANT MEDICATION CHANGES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEING TREATED WITH RBX2660 FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION200
855 CAN CYTOSPONGE HELP TRIAGE PATIENTS WHO CAN BE DISCHARGED FROM BARRETT'S SURVEILLANCE PROGRAMMES? A 2-YEAR SINGLE SITE UK STUDY194
Su1807 IBD MEDICATION USE IN PREGNANCY IS ASSOCIATED WITH A LOW RATE OF CONGENITAL ANOMALIES IN NEONATES: RESULTS FROM AN ANALYSIS OF THE BRITISH COLUMBIA POPULATION DATABASE.192
Tu1103 CROSS-SECTIONAL VS. LONG-TERM ADHERENCE TO COLORECTAL SCREENING IN A LARGE VA COHORT190
Su1776 EARLY AND RAPID USTEKINUMAB ADOPTION FOR INFLAMMATORY BOWEL DISEASE TREATMENT190
Mo1532 ANTIVIRAL TREATMENT AND ITS RESPONSE REDUCE DEVELOPMENT OF DEMENTIA AMONG HEPATITIS C VIRUS INFECTED PATIENTS IN THE U.S.186
Mo1501 A NOVEL PROGNOSTIC MODEL USING DONOR AND RECIPIENT CHARACTERISTICS TO PREDICT EARLY POST-TRANSPLANT MORTALITY IN PATIENTS WITH ACUTE LIVER FAILURE185
Tu1924 FORGOTTEN BUT STILL RELEVANT: VITAMIN C DEFICIENCY IN CHILDREN WITH COMPLEX MEDICAL PROBLEMS183
991 COST-EFFECTIVENESS OF RISK-STRATIFIED POST-HEPATECTOMY CARE PATHWAY IMPLEMENTATION178
Tu1493 RISK FACTORS OF DEVELOPING NONALCOHOLIC FATTY LIVER DISEASE FOLLOWING PANCREATIC RESECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS178
Sa1563 DEVELOPMENT AND VALIDATION OF A NOMOGRAM TO BETTER PREDICT SARCOPENIA IN NAFLD PATIENTS: AN INSIGHT FROM THE NHANES 2017-2018175
Tu1525 ALL THE MORE PEOPLE TO SCREEN: A LASTING IMPACT OF A QUALITY IMPROVEMENT INITIATIVE TO INCREASE HEPATITIS C SCREENING IN AN UNDERINSURED POPULATION175
228 LAPAROSCOPIC DISTAL PANCREATECTOMY BY RADICAL ANTEGRADE MODULAR PANCREATOSPLENECTOMY (RAMPS)174
1097 PATIENTS ADMITTED WITH ACUTE CHOLECYSTITIS AND ASSOCIATED COVID 19 HAD LESS RATES OF SAME ADMISSION CHOLECYSTECTOMY BUT NOT INCREASED MORTALITY162
Tu1750 A HIGHER VISCERAL ADIPOSE TISSUE BURDEN IS ASSOCIATED WITH HIGHER INFLIXIMAB CLEARANCE IN INFLAMMATORY BOWEL DISEASE160
Su1598 IS THERE A ROLE FOR PRE-EMPTIVE TIPS IN ACUTE VARICEAL BLEEDING? REAL WORLD DATA FROM A LOCAL ASIAN COHORT159
530 COMPARISON OF OUTCOMES FOR PATIENTS UNDERGOING SADI VS. RYGB IN 2020 AND 2021157
Sa2007 INSURANCE DELAYS BIOLOGIC AND SMALL MOLECULE TREATMENT OF PEDIATRIC IBD IN TERTIARY CARE CENTER153
Sa1916 THE EFFECT OF TEDUGLUTIDE ON THE UTILIZATION OF ENTERAL NUTRIENTS FOR THE SYNTHESIS OF HEPATIC, PANCREATIC AND MUCOSAL PROTEINS IN PATIENTS WITH SHORT BOWEL SYNDROME152
Sa2001 GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE148
Sa1834 VISCERAL ADIPOSITY INDEPENDENTLY PREDICTS TIME TO FLARE IN INFLAMMATORY BOWEL DISEASE, BUT BMI DOES NOT142
Sa1779 THE EPIDEMIOLOGY AND CHARACTERISTICS OF DE NOVO IBD AFTER SOLID ORGAN OR HEMATOPOIETIC STEM CELL TRANSPLANT BETWEEN 2011-2021: A LARGE POPOULATION-BASED STUDY142
Sa1829 TEMPORAL TRENDS IN 30-DAY AND 90-DAY HOSPITAL RE-ADMISSION RATES AMONG PERSONS WITH CROHN'S DISEASE IN THE POSTBIOLOGIC ERA: A POPULATION-BASED STUDY FROM A LARGE CANADIAN PROVINCE142
CME Exam 3: Abdominal Pain in a Young Adult141
Nausea, Vomiting, and Abdominal Distention After Atrial Fibrillation Therapy141
Efficacy and Safety of Drugs for Gastroparesis: Dopamine Receptor Antagonists Should Not Be Considered as a Single Pharmacologic Entity140
Conventional Endoscopic Mucosal Resection Versus Underwater Endoscopic Mucosal Resection: Is the Choice Straightforward?140
713e Longitudinal Analysis in A HNF4AΔIEC Mouse Colitis Model Reveals that Preclinical Flaring is Associated with Increased Akkermansia muciniphila Levels in the Gut Microbiome138
Reply137
775f The Introduction of Faecal Immunochemical Testing as a Triaging Tool for Colorectal Cancer Investigation During the COVID-19 Pandemic. A Service Evaluation and Report.137
560 SELECT AMINO ACIDS (AA-ORS) IMPROVE ELECTROLYTE AND FLUID ABSORPTION IN A RODENT DIARRHEA MODEL129
1042 MEDICATIONS AND RISK OF MICROSCOPIC COLITIS: A NATIONWIDE COHORT STUDY129
756 ELEVATED DIACYLGLYCEROL O-ACYLTRANSFERASES 1 AND 2 (DGAT1/2) REINFORCE A NEGATIVE REGULATORY LOOP OF LIPID DROPLETS AND FOXO3 TRANSCRIPTION FACTOR THAT DRIVES METABOLIC AND TUMEROGENIC REMODELING 123
1123 LOSS OF INTESTINAL EPITHELIAL DUOX2 SIGNALING IS ACCOMPANIED BY A REDUCTION IN AKKERMANSIACEAE AND PROMOTES THE DEVELOPMENT OF METABOLIC SYNDROME IN A MICROBIOME-DEPENDENT MANNER.123
1136 IMPROVED HEPATOCELLULAR CARCINOMA SURVEILLANCE WITH ANALYTICAL QUALITY IMPROVEMENT MEASURES, ELECTRONIC MEDICAL RECORD ALERTS COMBINED WITH PATIENT EDUCATION AND OUTREACH FOR PATIENTS WITH CIRRHO123
954 MESENCHYMAL STEM CELLS AMELIORATE INFLAMMATION IN AN EXPERIMENTAL MODEL OF CROHN'S DISEASE VIA THE MESENTERY122
1027 EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB REINDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER T121
478 NON-CANONICAL ACTIVIN A SIGNALING STIMULATES CONTEXTDEPENDENT AND CELLULAR-SPECIFIC OUTCOMES IN CRC TO PROMOTE TUMOR CELL MIGRATION AND TOLERANCE119
934 GERD-INDUCED ALTERATIONS IN HYDROGEN SULFIDE SIGNALING AS THE FUNDAMENTAL MECHANISM OF BARRETT'S ESOPHAGUS PATHOGENESIS119
140 FRAILTY IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY, COMPLICATIONS AND HOSPITAL COST IN PATIENTS ADMITTED WITH DECOMPENSATED CIRRHOSIS: A NATIONWIDE STUDY.119
Sa1526 INTERNAL BILIARY STENTS AND BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION: 16 YEARS OF EXPERIENCE IN A SINGLE CENTER118
Sa1525 RECENT IMMIGRANTS AND REFUGEES HAVE EQUAL RATES OF LIVER TRANSPLANTATION IN THE SETTING OF UNIVERSAL HEALTHCARE117
Sa1142 EFFECTS OF BIOLOGIC THERAPY IN PRIMARY SCLEROSING CHOLANGITIS WITH AND WITHOUT INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS116
Sa1193 RATIONALE FOR NEW SURVEILLANCE GUIDELINES FOR PATIENTS AT RISK OF PERITONEAL METASTASIS FROM COLON CANCER116
Sa1118 CHARACTERIZING DISEASE BURDEN AND RISK FACTORS IN LARYNGOPHARYNGEAL REFLUX DISEASE115
157 NEOPLASTIC PROGRESSION OF BARRETT'S ESOPHAGUS AMONG ORGAN TRANSPLANT RECIPIENTS: A CASE-CONTROL STUDY113
Mo1508 HOSPITAL TEACHING STATUS AND OUTCOMES IN PATIENTS WITH ESOPHAGEAL VARICEAL BLEEDING- A RETROSPECTIVE COHORT STUDY113
489 EATING HABITS AND SPECIFIC FOODS AND THEIR ASSOCIATION WITH GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA AND IBS111
Mo1521 THE GLOBAL BURDEN OF ALCOHOL-ASSOCIATED CIRRHOSIS AND CANCER IN YOUNG ADULTS110
Tu1452 ARTIFICIAL INTELLIGENCE ASSISTANCE OF PANCREATIC EXOCRINE INSUFFICIENCY EVALUATION IN CHRONIC PANCREATITIS FROM CONTRAST-ENHANCED CT110
Mo1532 PRESENCE OF MENTAL HEALTH DISORDERS IN PATIENTS WITH ALCOHOL USE REDUCES THE CHANCES FOR HEPATOLOGY REFERRAL DESPITE A HIGH FIB-4 INDEX110
Su1559 EFFECT OF ALCOHOL CONSUMPTION ON PEMAFIBRATE TREATMENT IN PATIENTS WITH FATTY LIVER AND HYPERTRIGLYCERIDEMIA109
Mo1886 VALIDATION OF THE USE OF ARTIFICIAL INTELLIGENCE FOR CLASSIFICATION OF ULCERATIVE COLITIS VS CROHN'S DISEASE IN PEDIATRIC PATIENTS109
Tu1888 METFORMIN IMPROVES INFLAMMATORY BOWEL DISEASE OUTCOMES IN PATIENTS WITH COMORBID TYPE 2 DIABETES MELLITUS106
Su1847 COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY: IMPACT OF MODERATE-TO-SEVERE CROHN'S DISEASE SYMPTOMS ON HEALTH CARE PROFESSIONAL TREATMENT DECISIONS IN THE UNITED STATES 106
Mo1750 EXPLORING THE RELATIONSHIP BETWEEN THE MEDITERRANEAN DIET AND BARRIER FUNCTION IN ULCERATIVE COLITIS104
Sa1225 DEVELOPMENT OF A PERSONALIZED HUMAN PANETH CELL MODEL USING INTESTINAL ORGANOIDS104
Mo1269 PERSONALIZED INTERVENTIONS FOR ESOPHAGEAL DYSMOTILITY PREVENTS EXTRA-ESOPHAGEAL COMPLICATIONS AND IMPROVES SURGICAL OUTCOMES IN LUNG TRANSPLANT RECIPIENTS104
Tu1617 INTEGRATION OF NORMOTHERMIC MACHINE PERFUSION IN A LIVER TRANSPLANT PROGRAM REDUCES WAITLIST TIME AND MORTALITY: A TWO-CENTER/ONE ENTERPRISE MODERN EXPERIENCE104
Mo1592 ANALYSIS OF INPATIENT ADMISSIONS AND MORTALITY RATE OF AUTOIMMUNE HEPATITIS (AIH), PRIMARY BILIARY CIRRHOSIS (PBC), AND PRIMARY SCLEROSING CHOLANGITIS (PSC): A UNITED STATES NATIONWIDE STUDY.103
Sa1611 HEPATITIS B VIRUS REACTIVATION IN CANCER PATIENTS RECEIVING CHEMOTHERAPY – A SYSTEMATIC REVIEW AND META-ANALYSIS103
Tu1958 INVESTIGATION OF FEEDING TUBE LONGEVITY FOR PERCUTANEOUS ENDOSCOPIC GASTROJEJUNOSTOMY (PEGJ) VS. DIRECT PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY (DPEJ) TUBES103
Sa2035 IBD PATIENT-DERIVED INTESTINAL ORGANOID PLATFORM FOR PRECISION MEDICINE102
Su1040 EFFECTS OF AN INTERVENTIONAL RADIOLOGY GUIDED TRAINING PROGRAM ON PARACENTESIS COMPETENCY AMONG INTERNAL MEDICINE RESIDENTS100
Su1948 APRAGLUTIDE TREATMENT IN SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE (SBS-IF) AND COLON-IN-CONTINUITY (CIC) IS ASSOCIATED WITH INCREASED ORAL INTAKE AND IMPROVED ENERGY AND CARBOHYDRATE ABSORP98
531 THE CONDITIONAL MUTATED RAD21 KNOCK-IN MOUSE MODEL FOR CHRONIC INTESTINAL PSEUDO-OBSTRUCTION: NEUROCHEMICAL AND FUNCTIONAL ANALYSIS98
829 UNDERSTANDING FRAGMENTED PANCREATIC CANCER CARE IN PATIENTS RECIEVING NEOADJUVANT THERAPY: ARE SOCIODEMOGRAPHIC DISPARITIES PREDICTIVE OF PATIENTS RECEIVING FRAGMENTED CARE?97
533 REGIONAL MICROBIOTA MISMATCHES FROM FECAL MICROBIOTA TRANSPLANTS DRIVE PERSISTENT, OFF-TARGET CONSEQUENCES TO THE HOST97
436 POSTOPERATIVE COMPLICATIONS TREND AFTER ILEO-J-POUCH-ANAL ANASTOMOSIS FOR INFLAMMATORY BOWEL DISEASE. A SYSTEMATIC LITERTURE REVIEW97
Sa1582 IN A NATIONAL COHORT OF VETERANS WITH SBP, SECONDARY SBP PROPHYLAXIS LINKS WITH GREATER SBP RECURRENCE COMPARED TO THOSE NOT STARTED ON PROPHYLAXIS AND THIS BURDEN IS WORSENING OVER TIME97
Tu2022 DEVELOPMENT OF AN ARTIFICIAL INTELLIGENCE MODEL TO IDENTIFY DUODENAL POLYPS IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS97
847 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): CONCORDANCE OF CLINICAL PROFILES AND NON-INVASIVE TESTS PERFORMANCE96
Su1524 GENETIC BIOMARKERS PREDICTING PROGNOSIS IN PATIENTS WITH CHOLANGIOCARCINOMA; A BIOINFORMATICS APPROACH STUDY96
Tu1996 USE OF AN AUTOMATED, DEEP LEARNING SOFTWARE TO EVALUATE BODY COMPOSITION INCLUDING SKELETAL MUSCLE MASS AND VISCERAL ADIPOSITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE93
Su1816 CAPILLARY BLOOD BASED SELF COLLECTION DEVICE FOR INFLIXIMAB THERAPEUTIC DRUG MONITORING93
Mo1591 ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF ELAFIBRANOR WITH INDOMETHACIN IN HEALTHY ADULT MALE PARTICIPANTS: AN OPEN-LABEL PHASE I TRIAL93
0.066245079040527